ストックスクリーナーアプリを入手
0.8201
12.72%
-0.1195
アフターアワーズ：
.82
-0.0001
-0.01%
前日終値:
$0.9396
開ける：
$0.9095
24時間の取引高:
200.04K
Relative Volume:
0.67
時価総額：
$22.20M
収益：
-
当期純損益:
$-1.40M
株価収益率:
-3.9542
EPS:
-0.2074
ネットキャッシュフロー:
$-10.49M
1週間 パフォーマンス:
+34.44%
1か月 パフォーマンス:
-5.08%
6か月 パフォーマンス:
-86.94%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.80
$0.9399
1週間の範囲:
$0.63
$0.94
52週間の値動き範囲:
$0.61
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
LIMN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.8201 | 25.43M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Liminatus Pharma Inc (LIMN) 最新ニュース
What insider trading reveals about Liminatus Pharma Inc. stockWeekly Trend Summary & Smart Investment Allocation Insights - ulpravda.ru
Is Liminatus Pharma Inc. Equity Warrant stock oversold or undervaluedQuarterly Trade Report & Free Safe Capital Growth Stock Tips - ulpravda.ru
Will Liminatus Pharma Inc. stock see insider buying2025 Year in Review & Smart Investment Allocation Insights - ulpravda.ru
Will Liminatus Pharma Inc. stock benefit from AI adoptionJuly 2025 Big Picture & Real-Time Buy Signal Notifications - ulpravda.ru
What Wall Street predicts for Liminatus Pharma Inc. stock priceJuly 2025 Selloffs & Accurate Intraday Trading Signals - ulpravda.ru
Growth Value: Can Liminatus Pharma Inc. stock beat market expectations this quarterJuly 2025 Drop Watch & Detailed Earnings Play Alerts - ulpravda.ru
Published on: 2026-01-09 01:14:45 - ulpravda.ru
Is Liminatus Pharma Inc. stock affected by interest rate hikesJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Is Liminatus Pharma Inc. stock oversold or undervaluedJuly 2025 Recap & Daily Oversold Bounce Ideas - ulpravda.ru
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Where Could Kokuyo Camlin Limited (523207) Be HeadedLow Beta Stocks & Free Expert Guidance For Growth - earlytimes.in
Tamilnadu Petroproducts Limited Price Holds Above Key Fib LevelTrading Volume Trends & Small Entry Trading Portfolio - bollywoodhelpline.com
Inhibikase Therapeutics (NASDAQ:IKT) vs. Liminatus Pharma (NASDAQ:LIMN) Financial Survey - Defense World
How to find a Compounding MachineMarket Sentiment Extremes & Explosive Growth Trading - bollywoodhelpline.com
Liminatus Pharma files to sell 6.9M shares of common stock - MSN
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
What is the current Price Target and Forecast for Liminatus Pharma Inc. (LIMN) - Zacks Investment Research
Contrasting Inhibikase Therapeutics (NASDAQ:IKT) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Can Liminatus Pharma Inc. Equity Warrant stock beat market expectations this quarterTreasury Yields & Reliable Trade Execution Plans - Bölüm Sonu Canavarı
Inhibikase Therapeutics (NASDAQ:IKT) and Liminatus Pharma (NASDAQ:LIMN) Head to Head Contrast - Defense World
Analyzing Liminatus Pharma (NASDAQ:LIMN) and Inhibikase Therapeutics (NASDAQ:IKT) - Defense World
Can Liminatus Pharma Inc. stock beat market expectations this quarterMarket Activity Report & Weekly High Return Forecasts - Улправда
Should I hold or sell YORW stock in 2025Trade Performance Summary & Reliable Entry Point Trade Alerts - moha.gov.vn
Published on: 2025-12-21 01:33:15 - Улправда
Will Liminatus Pharma Inc. Equity Warrant stock maintain dividend yieldPortfolio Risk Summary & Capital Efficient Trade Techniques - bolumsonucanavari.com
Market Pulse: What Wall Street predicts for Liminatus Pharma Inc. stock priceTrade Exit Summary & High Yield Stock Recommendations - Bölüm Sonu Canavarı
How Liminatus Pharma Inc. Equity Warrant stock compares to industry benchmarks2025 Price Action Summary & Short-Term High Return Ideas - Улправда
Is Liminatus Pharma Inc. stock in correction or buying zone2025 Growth vs Value & Reliable Entry Point Alerts - Улправда
Can Liminatus Pharma Inc. stock outperform in 2025 bull market2025 Year in Review & Safe Investment Capital Preservation Plans - Улправда
Published on: 2025-12-19 21:14:50 - Улправда
Why Liminatus Pharma Inc. Equity Warrant stock is in analyst buy zoneQuarterly Risk Review & Real-Time Volume Surge Alerts - Bölüm Sonu Canavarı
Can Liminatus Pharma Inc. stock hit record highs again2025 Price Momentum & Trade Opportunity Analysis - DonanımHaber
Why Liminatus Pharma Inc. Equity Warrant stock remains on buy listsPrice Action & High Accuracy Investment Signals - Улправда
Bear Alert: Can Liminatus Pharma Inc stock hit record highs againJuly 2025 Reactions & Low Drawdown Trading Strategies - moha.gov.vn
Is Liminatus Pharma Inc. Equity Warrant stock a buy for dividend growthDollar Strength & Verified High Yield Trade Plans - Улправда
Published on: 2025-12-18 21:46:16 - Улправда
Published on: 2025-12-18 20:43:25 - Улправда
Contrasting Inhibikase Therapeutics (NASDAQ:IKT) & Liminatus Pharma (NASDAQ:LIMN) - Defense World
Investment Recap: Will Liminatus Pharma Inc stock benefit from AI adoptionPrice Action & AI Forecasted Entry and Exit Points - moha.gov.vn
Liminatus Pharma (LIMNW) Stock Analysis Report | Financials & Insights - Benzinga
LIMNW Stock Institutional Owners - Quiver Quantitative
Will Liminatus Pharma Inc. stock reach Wall Street targetsPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
What sentiment indicators say about Liminatus Pharma Inc. Equity Warrant stockEarnings Trend Report & Real-Time Buy Signal Alerts - Newser
Is Liminatus Pharma Inc. stock trading at a premium valuationTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Chart Watch: Can TriCo Bancshares stock beat market expectations this quarterCPI Data & Daily Volume Surge Signals - BỘ NỘI VỤ
Reviewing Vor Biopharma (NASDAQ:VOR) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Will Liminatus Pharma Inc. Equity Warrant stock outperform Dow Jones indexPortfolio Gains Summary & Risk Controlled Daily Plans - moha.gov.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Liminatus Pharma Faces Nasdaq Non-Compliance Notice - MSN
Liminatus Pharma receives Nasdaq notice for non-compliance with listing standards - Investing.com India
LIMN gets Nasdaq warnings over market value and listing rules - Stock Titan
Liminatus Pharma Inc (LIMN) 財務データ
収益
当期純利益
現金流量
EPS
0.80%
4.56%
大文字化:
|
ボリューム (24 時間):